Florida / New York / No Carolina
Ph: 561.316.3330

The Global Biomanufacturing Market Report 2024-2035, with Profiles of 1000+ Companies at the Forefront of Biomanufacturing Innovation

Summation

  • The report offers a detailed overview of biomanufacturing processes, technologies, and host organisms, highlighting the importance of this industry in the global economy.
  • The biomanufacturing market is a rapidly growing sector that involves the production of various products using biological systems, such as living cells, enzymes, or other biological components.
  • These sub-markets represent the diverse applications of biomanufacturing and highlight the growing importance of biological processes in various sectors of the economy.

The Global Biomanufacturing Markets 2024-2035 is a comprehensive market report that explores the rapidly evolving landscape of biomanufacturing technologies and applications. This in-depth analysis covers key sectors such as biopharmaceuticals, industrial enzymes, biofuels, bioplastics, biochemicals, and bio-agritech, providing insights into market trends, growth opportunities, and the competitive landscape. The report offers a detailed overview of biomanufacturing processes, technologies, and host organisms, highlighting the importance of this industry in the global economy. It covers production methods, including microbial fermentation, mammalian cell culture, and plant-based systems, as well as upstream and downstream processing technologies.

The biomanufacturing market is a rapidly growing sector that involves the production of various products using biological systems, such as living cells, enzymes, or other biological components. The market encompasses a wide range of applications, from biopharmaceuticals and industrial enzymes to biofuels and bio-based chemicals. Biomanufacturing processes often rely on renewable feedstocks and generate less waste compared to traditional chemical manufacturing methods. This makes biomanufacturing a more sustainable and environmentally friendly approach to producing various products.

Biological systems can produce complex molecules with high specificity and purity, which is particularly important for the production of biopharmaceuticals and other high-value products. Biomanufacturing enables the production of novel and superior products that may be difficult or impossible to obtain through chemical synthesis. Biomanufacturing plays a crucial role in addressing global challenges, such as healthcare, energy security, and environmental sustainability. For example, biopharmaceuticals produced through biomanufacturing processes have revolutionized the treatment of various diseases, while biofuels and bio-based chemicals offer alternatives to fossil-based products.

Biomanufacturing encompasses several sub-markets, covered in this report including:

  • Biopharmaceuticals: production of drugs and vaccines using living cells or their components. It includes the manufacture of monoclonal antibodies, recombinant proteins, cell and gene therapies, and other biologics.
  • Industrial enzymes: enzymes produced through biomanufacturing processes are used in various industries, such as food and beverage, textiles, detergents, and paper and pulp. These enzymes catalyze specific reactions and improve the efficiency of industrial processes.
  • Biofuels: biomanufacturing technologies are used to produce sustainable fuels, such as bioethanol and biodiesel, from renewable feedstocks like corn, sugarcane, or algae.
  • Bio-based chemicals: production of chemicals, such as platform chemicals, specialty chemicals, and polymers, using biological processes. These chemicals serve as building blocks for various industries, including plastics, pharmaceuticals, and consumer products.
  • Biomaterials: materials derived from biological sources, such as bioplastics, bio-based composites, and biominerals. These materials find applications in packaging, construction, and medical devices.
  • Agricultural biologicals: production of biopesticides, biofertilizers, and other biological products used in agriculture to enhance crop productivity and protect against pests and diseases.
  • Flavors and fragrances: Biomanufacturing processes are used to produce natural flavors, fragrances, and other sensory ingredients for the food, beverage, and cosmetic industries.
  • Synthetic biology products: production of novel products and materials designed using synthetic biology principles, such as engineered microorganisms, biosynthetic pathways, and genetic circuits.

These sub-markets represent the diverse applications of biomanufacturing and highlight the growing importance of biological processes in various sectors of the economy. As technology advances, new sub-markets may emerge, further expanding the scope of biomanufacturing.

The report features profiles of over 1,000 companies at the forefront of biomanufacturing innovation, offering valuable insights into their technologies, products, and strategic initiatives.

Companies profiled include Aanika Biosciences, Amyris, BBGI, Biovectra, Bucha Bio, Byogy Renewables, Cascade Biocatalysts, Constructive Bio, Debut Biotechnology, Enginzyme AB, eversyn, Erebagen, Eligo Bioscience, Evolutor, EV Biotech, FabricNano, Ginkgo Bioworks, Hyfe, Invizyne Technologies, LanzaTech, Lygos, Mammoth Biosciences, Novozymes A/S, NTx, Origin Materials, Pow.bio, Protein Evolution, Solugen, Synthego, Taiwan Bio-Manufacturing Corp. (TBMC), Twist Bioscience, Uluu, Van Heron Labs, Verde Bioresins, and ZymoChem.

Key Topics Covered:

1 Executive Summary

1.1 Definition and Scope of Biomanufacturing

1.2 Overview of Biomanufacturing Processes

1.3 Key Components of Biomanufacturing

1.4 Importance of Biomanufacturing in the Global Economy

1.5 Markets

2 Production

2.1 Microbial Fermentation

2.2 Mammalian Cell Culture

2.3 Plant Cell Culture

2.4 Insect Cell Culture

2.5 Transgenic Animals

2.6 Transgenic Plants

2.7 Technologies

2.8 Scale of Production

2.9 Mode of Operation

2.10 Host Organisms

3 Biopharmaceuticals

3.1 Technology/materials analysis

3.1.1 Monoclonal Antibodies (mAbs)

3.1.2 Recombinant Proteins

3.1.3 Vaccines

3.1.4 Cell and Gene Therapies

3.1.5 Blood Factors

3.1.6 Tissue Engineering Products

3.1.7 Nucleic Acid Therapeutics

3.1.8 Peptide Therapeutics

3.1.9 Biosimilars and Biobetters

3.1.10 Nanobodies and Antibody Fragments

3.1.11 Synthetic biology

3.1.12 Generative biology

3.2 Market analysis

3.2.1 Key players and competitive landscape

3.2.2 Market Growth Drivers and Trends

3.2.3 Regulations

3.2.4 Value chain

3.2.5 Future outlook

3.2.6 Addressable Market Size

3.2.7 Risks and Opportunities

3.2.8 Global revenues

3.3 Company profiles (113 company profiles)

4 Industrial Enzymes

4.1 Technology/materials analysis

4.1.1 Detergent Enzymes

4.1.2 Food Processing Enzymes

4.1.3 Textile Processing Enzymes

4.1.4 Paper and Pulp Processing Enzymes

4.1.5 Leather Processing Enzymes

4.1.6 Biofuel Production Enzymes

4.1.7 Animal Feed Enzymes

4.1.8 Pharmaceutical and Diagnostic Enzymes

4.1.9 Waste Management and Bioremediation Enzymes

4.1.10 Agriculture and Crop Improvement Enzymes

4.2 Market analysis

4.2.1 Key players and competitive landscape

4.2.2 Market Growth Drivers and Trends

4.2.3 Regulations

4.2.4 Value chain

4.2.5 Future outlook

4.2.6 Addressable Market Size

4.2.7 Risks and Opportunities

4.2.8 Global revenues

4.3 Companies profiles (75 company profiles)

5 Biofuels

5.1 Technology/materials analysis

5.1.1 Role in the circular economy

5.1.2 The global biofuels market

5.1.3 Feedstocks

5.1.4 Bioethanol

5.1.5 Biodiesel

5.1.6 Biogas

5.1.7 Biobutanol

5.1.8 Biohydrogen

5.1.9 Biomethanol

5.1.10 Bio-oil and Biochar

5.1.11 Renewable Diesel and Jet Fuel

5.1.12 Algal biofuels

5.2 Market analysis

5.2.1 Key players and competitive landscape

5.2.2 Market Growth Drivers and Trends

5.2.3 Regulations

5.2.4 Value chain

5.2.5 Future outlook

5.2.6 Addressable Market Size

5.2.7 Risks and Opportunities

5.2.8 Global revenues

5.3 Company profiles (213 company profiles)

6 Bioplastics

6.1 Technology/materials analysis

6.1.1 Polylactic acid (PLA)

6.1.2 Polyhydroxyalkanoates (PHAs)

6.1.3 Bio-based polyethylene (PE)

6.1.4 Bio-based polyethylene terephthalate (PET)

6.1.5 Bio-based polyurethanes (PUs)

6.1.6 Starch-based plastics

6.1.7 Cellulose-based plastics

6.2 Market analysis

6.2.1 Key players and competitive landscape

6.2.2 Market Growth Drivers and Trends

6.2.3 Regulations

6.2.4 Value chain

6.2.5 Future outlook

6.2.6 Addressable Market Size

6.2.7 Risks and Opportunities

6.2.8 Global revenues

6.3 Company profiles (520 company profiles)

7 Biochemicals

7.1 Technology/materials analysis

7.2 Market analysis

7.3 Company profiles (117 company profiles)

8 Bio-Agritech

8.1 Technology/materials analysis

8.1.1 Biopesticides

8.1.2 Biofertilizers

8.1.3 Biostimulants

8.1.4 Agricultural Enzymes

8.2 Market analysis

8.2.1 Key players and competitive landscape

8.2.2 Market Growth Drivers and Trends

8.2.3 Regulations

8.2.4 Value chain

8.2.5 Future outlook

8.2.6 Addressable Market Size

8.2.7 Risks and Opportunities

8.2.8 Global revenues

8.3 Company profiles (151 company profiles)

A selection of companies mentioned in this report includes:

  • Aanika Biosciences
  • Amyris
  • BBGI
  • Biovectra
  • Bucha Bio
  • Byogy Renewables
  • Cascade Biocatalysts
  • Constructive Bio
  • Debut Biotechnology
  • Eligo Bioscience
  • Enginzyme AB
  • Erebagen
  • EV Biotech
  • eversyn
  • Evolutor
  • FabricNano
  • Ginkgo Bioworks
  • Hyfe
  • Invizyne Technologies
  • LanzaTech
  • Lygos
  • Mammoth Biosciences
  • Novozymes A/S
  • NTx
  • Origin Materials
  • Pow.bio
  • Protein Evolution
  • Solugen
  • Synthego
  • Taiwan Bio-Manufacturing Corp. (TBMC)
  • Twist Bioscience
  • Uluu
  • Van Heron Labs
  • Verde Bioresins
  • ZymoChem

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

Flow Cytometry Market Surges to $10.3 Billion by 2032, Driven by 9.2% CAGR Growth

The global flow cytometry market, valued at $5.1 billion in 2024, is primed for substantial growth, projected to achieve a remarkable compound annual growth rate (CAGR) of 9.2% over the forecast period, ultimately reaching $10.3 billion by 2032.

Medical Laser Market to Be Worth $17.3 Billion by 2031

According to a new market research report titled, 'Medical Laser Market by Type (Device Type (Solid-state Lasers, Gas Lasers, Dye Lasers, Diode Lasers), Fiber Type (Disposable Laser Fibers, Reusable Laser Fibers)), Application (Device, Fiber), and Geography—Global Forecast to 2031,' the medical laser market is projected to reach $17.3 billion by 2031, at a CAGR of 17.6% from 2024–2031.

Ambulatory EHR Market to be Worth $7.84 billion by 2031 – Exclusive Report

Ambulatory electronic health record (EHR) software is designed for outpatient care settings, enabling medical professionals to access a patient's complete medical history stored in an electronic format.

By using this website you agree to accept Medical Device News Magazine Privacy Policy